June 25, 2007 – Arisaph Pharmaceuticals Announces Results Of Its Potent Smart DPP-IV Inhibitor, ARI-2243, At The ADA.
// view PDF
June 30, 2006 – Dr. Antonio Gotto, Jr. To Join Board Of Directors And Scientific Advisory Board Of Arisaph Pharmaceuticals.
// view PDF
June 30, 2006 – Arisaph Pharmaceuticals Announces Appointments Of Scientific Advisory Board Members.
// view PDF
February 24, 2006 – Arisaph Pharmaceuticals Grants Non-Exclusive License Under Dipeptidyl Peptidase (DPP-IV) Patents.
// view PDF
November 14, 2005 – Arisaph Reports On Promising Results Presented At AHA: Novel APO A-I Mimetic Peptide Significantly Inhibits Atherosclerosis In Precinical Animal Study.
// view PDF
November 14, 2005 – Triad Pharmaceuticals Adopts New Name Of Arisaph Pharmaceuticals.
// view PDF